Hudkræftklinikken.dk ApS: Financial statements 2019
CVR: 38219960
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Hudkræftklinikken.dk ApS (CVR 38219960) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,116,482 and a net result of DKK -819,454 compared with DKK 57,766 the year before. That is an increase of 29.1% compared with the year before. Equity in the 2019 report amounted to DKK 2,220,563. The solvency ratio was 80.1%.
- Gross Profit
- DKK 2,116,482
- Profit/Loss
- DKK -819,454
- Equity
- DKK 2,220,563
- Total Assets
- DKK 2,771,403
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Hudkræftklinikken.dk ApS has published its annual report for 2018. Gross profit came to DKK 1,640,026, and the net result was DKK 57,766.
About Hudkræftklinikken.dk ApS
Hudkræftklinikken.dk ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Speciallægers aktiviteter. The company was previously named Hudkræftklinikken.dk Anpartsselskab. The management consists of Bolette Birch Bengtsen. The board consists of Robert Birger Birch (chair), Kent Stevens Larsen and Martin Glud. The company's owners include Birch Bengtsen Invest ApS, PHOENIX CAPITAL ApS and M.Glud holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 1,898,097 and a net result of DKK -210,331 compared with DKK 9,266 the year before. Equity in the 2025 report amounted to DKK 757,000.